Scienture (SCNX) announces the U.S. Food and Drug Administration, FDA, has approved SCN-102, one of the products being developed by Scienture, ...

Imagine receiving a diagnosis that changes your life in an instant: hypertrophic cardiomyopathy, a heart condition that can strike without warning, claiming thousands of lives annually .

HeartLung Technologies selected as a finalist and will compete at the ACC 2025 Innovation Pitch Challenge in Chicago. Marlon Montes HeartLung Corporation +1 310-510-6004 ... Visit us on social media: ...

HeartLung Technologies to debut its FDA designated "Breakthrough" AI technology (AutoChamberTM) at ACC 2025, offering lifesaving AI solutions for CVD prevention. Marlon Montes HeartLung Corporation +1 ...

Despite having cardiovascular risk factors, asymptomatic aircraft pilots referred for medical screenings demonstrate favorable long-term outcomes and a low risk for major cardiac events.

Sirolimus, the active ingredient in Felycin-CA1, at a higher dose is used as an immunosuppressant in human patients receiving ...

A recent study has highlighted the sex-specific implications of myocardial fibrosis on mortality in patients with severe ...

Discover why high blood pressure earned its "silent killer" nickname, how it damages organs without symptoms, and the ...

The prevalence of LVH increased progressively across METS-VF quartiles, ranging from 7.9% to 31%. Higher METS-VF levels were ...

Lehigh Valley Health Network, part of Jefferson Health, expects to open its fourth neighborhood hospital next year in ...

Objectives To determine the prognostic value of patterns of right ventricular adaptation in patients with pulmonary arterial hypertension (PAH), assessed using cardiac magnetic resonance (CMR) imaging ...